Excluding the typical patient: Thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder

Annals of Clinical Psychiatry

Volumn 26, Issue 1, 2014, Pages 39-46

  Odlaug, Brian L ^a   Weinhandl, Eric ^b   Mancebo, Maria C ^c   Mortensen, Erik L ^a   Eisen, Jane L ^c   Rasmussen, Steven A ^c   Schreiber, Liana R N ^d   Grant, Jon E ^e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Anxiety disorders; Clinical trials; Drug therapy; Obsessive compulsive disorder

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; PLACEBO; SERTRALINE;

ADULT; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COMMUNITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DSM-IV; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDLINE; MENTAL PATIENT; OBSESSIVE COMPULSIVE DISORDER; PATIENT SATISFACTION; META ANALYSIS; PATIENT SELECTION; REVIEW; STANDARD;

CLINICAL TRIALS AS TOPIC; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PATIENT SELECTION;

EID: 84907003626     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Veldhuis J, Dieleman JP, Wohlfarth T, et al. Incidence and prevalence of "diagnosed OCD" in a primary care, treatment seeking, population. Int J Psychiatry Clin Pract. 2012;16:85-92.
2. Fireman B, Koran LM, Leventhal JL, et al. The preva-lence of clinically recognized obsessive-compulsive dis-order in a large health maintenance organization. Am J Psychiatry. 2001;158:1904-1910.
3. Coles ME, Heimberg RG, Weiss BD. The public's knowledge and beliefs about obsessive compulsive disor-der. Depress Anxiety. 2013;30:778-785.
4. Fullana MA, Mataix-Cols D, Caspi A, et al. Obsessions and compulsions in the community: prevalence, inter-ference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am J Psychiatry. 2009;166:329-336.
5. Ruscio AM, Stein DJ, Chiu WT, et al. The epidemi-ology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010; 15:53-63.
6. Karno M, Golding JM, Sorenson SB, et al. The epide-miology of obsessive-compulsive disorder in five US com-munities. Arch Gen Psychiatry. 1998;45:1094-1099.
7. Mathers CD, Vos T, Lopez AD, et al, eds. National burden of disease studies: a practical guide. Edition 2.0. Global Program on Evidence for Health Policy. Geneva, Switzerland: World Health Organization; 2001.
8. Soomro GM, Altman D, Rajagopal S, et al. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008;23:CD001765.
9. Ackerman DL, Greenland S, Bystritsky A, et al. Predictors of treatment response in obsessive com-pulsive disorder: multivariate analyses from a multi-center trial of clomipramine. J Clin Psychopharmacol. 1994;14:247-254.
10. Greist JH, Jefferson JW, Kobak KA, et al. Efficacy and tolerability of serotonin transport inhibitors in obses-sive-compulsive disorder: a meta analysis. Arch Gen Psychiatry. 1995;52:53-60.
11. Mancebo MC, Eisen JL, Pinto A, et al. The Brown longitudinal obsessive compulsive study: treatments received and patient impressions of improvement. J Clin Psychiatry. 2006;67:1713-1720.
12. Erzgovesi S, Cavallini MC, Cavedini P, et al. Clinical predictors of drug response in obsessive-compulsive dis-order. J Clin Psychopharmacol. 2001;21:488-492.
13. Shetti CN, Reddy YC, Kandavel T, et al. Clinical pre-dictors of drug nonresponse in obsessive-compulsive dis-order. J Clin Psychiatry. 2005;66:1517-1523.
14. Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1999;56:121-127.
15. Ravizza L, Barzega G, Bellino S, et al. Predictors of drug treatment response in obsessive-compulsive disor-der. J Clin Psychiatry. 1995;56:368-373.
16. Marcks BA, Weisberg RB, Dyck I, et al. Longitudinal course of obsessive-compulsive disorder in patients with anxiety disorders: a 15-year prospective follow-up study. Compr Psychiatry. 2011;52:670-677.
17. Ferrão YA, Shavitt RG, Bedin NR, et al. Clinical fea-tures associated to refractory obsessive-compulsive disor-der. J Affect Disord. 2006;94:199-209.
18. Grimshaw L. The outcome of obsessional dis-order a follow-up study of 100 cases. Br J Psychiatry. 1965;111:1051-1056.
19. Eisen JL, Goodman WK, Keller MB, et al. Patterns of remission and relapse in obsessive-compulsive dis-order: a 2-year prospective study. J Clin Psychiatry. 1999;60:346-351.
20. Eisen JL, Pinto A, Mancebo MC, et al. A 2-year pro-spective follow-up study of the course of obsessive-com-pulsive disorder. J Clin Psychiatry. 2010;71:1033-1039.
21. Zetin M, Hoepner CT. Relevance of exclusion criteria in antidepressant clinical trials: a replication study. J Clin Psychopharmacol. 2007;27:295-301.
22. Zimmerman M, Mattia JI, Posternak MA. Are sub-jects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry. 2002;159:469-473.
23. Okuda M, Hasin DS, Olfson M, et al. Generalizability of clinical trials for cannabis dependence to community samples. Drug Alcohol Depend. 2010;111:177-181.
24. Streiner DL, Norman GR. Efficacy and effectiveness trials. Community Oncology. 2009;6:472-474.
25. Pinto A, Mancebo MC, Eisen JL, et al. The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. J Clin Psychiatry. 2006;67:703-711.
26. Mancebo MC, Eisen JL, Sibrava NJ, et al. Patient uti-lization of cognitive-behavioral therapy for OCD. Behav Ther. 2011;42:399-412.
27. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1996.
28. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006-1011.
29. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
30. Rasmussen SA, Eisen JL. The epidemiology and dif-ferential diagnosis of obsessive compulsive disorder. J Clin Psychiatry. 1994;55(suppl 5):5-10.
31. Pallanti S, Grassi G, Sarrecchia ED, et al. Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry. 2011; 2:70.
32. Perugi G, Akiskal HS, Pfanner C, et al. The clini-cal impact of bipolar and unipolar affective comorbid-ity on obsessive-compulsive disorder. J Affect Disord. 1997;46:15-23.
33. Pigott TA, L'Heureux F, Dubbert B, et al. Obsessive compulsive disorder: comorbid conditions. J Clin Psychiatry. 1994;55(suppl):15-27.
34. Tükel R, Tihan AK, Oztürk N. A comparison of comor-bidity in body dysmorphic disorder and obsessive-com-pulsive disorder. Ann Clin Psychiatry. 2013;25:210-216.
35. Klein Hofmeijer-Sevink M, van Oppen P, van Megen HJ, et al. Clinical relevance of comorbidity in obsessive compulsive disorder: The Netherlands OCD Association study. J Affect Disord. 2013;150:847-854.
36. Fineberg NA, Hengartner MP, Bergbaum C, et al. Lifetime comorbidity of obsessive-compulsive disorder and sub-threshold obsessive-compulsive symptomatol-ogy in the community: impact, prevalence, socio-demo-graphic and clinical characteristics. Int J Psychiatry Clin Pract. 2013;17:188-196.
37. Fineberg NA, Reghunandanan S, Brown A, et al. Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond. Aust N Z J Psychiatry. 2013;47:121-141.
38. Olatunji BO, Davis ML, Powers MB, et al. Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. J Psychiatr Res. 2013;47:33-41.
39. Storch EA, Mariaskin A, Murphy TK. Psychotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep. 2009;11:296-301.
40. Belotto-Silva C, Diniz JB, Malavazzi DM, et al. Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: a practical clinical trial. J Anxiety Disord. 2012;26:25-31.